author-photo

Daoxiong Chen

9

Papers

15

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

The DAWN study of dorzagliatin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial

2021
Show All
- Source
- Cite
- Save
Citations (0)
Low prevalence of vitamin D deficiency in adult residents in Hainan, the tropical island province of China

2021 Annals of palliative medicine
Show All
- Source
- Cite
- Save
Citations (0)
Henagliflozin Monotherapy in Patients with Type 2 Diabetes Inadequately Controlled on Diet and Exercise: A Randomized, Double-blind, Placebo-controlled, Phase 3 Trial

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and safety of polyethylene glycol loxenatide (PEX168) monotherapy in type 2 diabetes patients: a multicenter, randomized, double-blind, placebo-controlled, phase 3a clinical trial.

2020 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (2)
Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report

2019 Journal of Medical Case Reports
Show All
- Source
- Cite
- Save
Citations (3)
A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus

2017 Experimental and Therapeutic Medicine
Show All
- Source
- Cite
- Save
Citations (5)
Exenatide enhances INS-1 rat pancreatic β‑cell mass by increasing the protein levels of adiponectin and reducing the levels of C-reactive protein

2014 Molecular Medicine Reports
Show All
- Source
- Cite
- Save
Citations (3)